KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to $3.3 billion.

  • Thermo Fisher Scientific's Cost of Revenue rose 470.03% to $3.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $12.9 billion, marking a year-over-year increase of 76.42%. This contributed to the annual value of $12.7 billion for FY2024, which is 390.34% down from last year.
  • According to the latest figures from Q3 2025, Thermo Fisher Scientific's Cost of Revenue is $3.3 billion, which was up 470.03% from $3.2 billion recorded in Q2 2025.
  • Over the past 5 years, Thermo Fisher Scientific's Cost of Revenue peaked at $3.7 billion during Q4 2022, and registered a low of $33.0 million during Q4 2021.
  • In the last 5 years, Thermo Fisher Scientific's Cost of Revenue had a median value of $3.3 billion in 2025 and averaged $3.2 billion.
  • Per our database at Business Quant, Thermo Fisher Scientific's Cost of Revenue tumbled by 9890.04% in 2021 and then skyrocketed by 1048787.88% in 2022.
  • Thermo Fisher Scientific's Cost of Revenue (Quarter) stood at $3.6 billion in 2021, then grew by 1.8% to $3.7 billion in 2022, then dropped by 9.32% to $3.3 billion in 2023, then fell by 2.99% to $3.2 billion in 2024, then increased by 2.47% to $3.3 billion in 2025.
  • Its Cost of Revenue stands at $3.3 billion for Q3 2025, versus $3.2 billion for Q2 2025 and $3.1 billion for Q1 2025.